Literature DB >> 28741472

Chromatin Structure Profiling Identifies Crucial Regulators of Tumor Maintenance.

Constanze Bonifer1, Peter N Cockerill2.   

Abstract

Cancer is primarily caused by mutations in genes encoding transcriptional regulators and signaling molecules. These mutations cooperate to deregulate the tight control over gene expression that is otherwise seen in normal cells. One consequence of this process is deregulated transcription factor (TF) activity. This forum article highlights novel strategies that use genome-wide chromatin structure profiling to identify the deregulated factors on which cancer cells depend, with the ultimate aim of targeting them.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; chromatin structure profiling; open chromatin; regulators of cancer biology; transcription factors

Year:  2015        PMID: 28741472     DOI: 10.1016/j.trecan.2015.10.003

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  5 in total

Review 1.  T Cell Receptor and Cytokine Signaling Can Function at Different Stages to Establish and Maintain Transcriptional Memory and Enable T Helper Cell Differentiation.

Authors:  Sarah L Bevington; Pierre Cauchy; David R Withers; Peter J L Lane; Peter N Cockerill
Journal:  Front Immunol       Date:  2017-03-03       Impact factor: 7.561

2.  A switch in transcription and cell fate governs the onset of an epigenetically-deregulated tumor in Drosophila.

Authors:  Jorge V Beira; Renato Paro; Joana Torres; Remo Monti; Ariane L Moore; Makiko Seimiya; Yanrui Jiang; Niko Beerenwinkel; Christian Beisel
Journal:  Elife       Date:  2018-03-21       Impact factor: 8.140

3.  Subtype-specific regulatory network rewiring in acute myeloid leukemia.

Authors:  Salam A Assi; Maria Rosaria Imperato; Daniel J L Coleman; Anna Pickin; Sandeep Potluri; Anetta Ptasinska; Paulynn Suyin Chin; Helen Blair; Pierre Cauchy; Sally R James; Joaquin Zacarias-Cabeza; L Niall Gilding; Andrew Beggs; Sam Clokie; Justin C Loke; Phil Jenkin; Ash Uddin; Ruud Delwel; Stephen J Richards; Manoj Raghavan; Michael J Griffiths; Olaf Heidenreich; Peter N Cockerill; Constanze Bonifer
Journal:  Nat Genet       Date:  2018-11-12       Impact factor: 38.330

4.  RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

Authors:  Anetta Ptasinska; Anna Pickin; Salam A Assi; Paulynn Suyin Chin; Luke Ames; Roberto Avellino; Stefan Gröschel; Ruud Delwel; Peter N Cockerill; Cameron S Osborne; Constanze Bonifer
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.423

5.  In-silico probing of AML related RUNX1 cancer-associated missense mutations: Predicted relationships to DNA binding and drug interactions.

Authors:  Hanif Ullah; Baoyun Zhang; Narendra Kumar Sharma; Pierre D McCrea; Yogesh Srivastava
Journal:  Front Mol Biosci       Date:  2022-08-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.